Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Peptide API CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer comprehensive support for the development, manufacturing, and production of peptide active pharmaceutical ingredients (APIs). These services are essential for the pharmaceutical and biotechnology industries, facilitating the production of peptides for therapeutic purposes.

The global Peptide API CDMO Services market size is projected to grow from US$ 2291 million in 2024 to US$ 5489 million in 2030; it is expected to grow at a CAGR of 15.7% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Peptide API CDMO Services Industry Forecast” looks at past sales and reviews total world Peptide API CDMO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide API CDMO Services sales for 2023 through 2029. With Peptide API CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide API CDMO Services industry.

This Insight Report provides a comprehensive analysis of the global Peptide API CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide API CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide API CDMO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide API CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide API CDMO Services.

Global key players of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, Thermo Fisher, etc. The top five players hold a share over 54%. North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately. In terms of product type, GMP Services is the largest segment, occupied for a share of 72%. In terms of application, Commercial has a share about 75 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide API CDMO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
GMP Services
Non-GMP Services

Segmentation by Application:
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
GMP Services
Non-GMP Services

Segmentation by Application:
Commercial
Scientific Research
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermo Fisher
Bio Basic
JPT
Genscript
Chinese Peptide Company
ScinoPharm
ChengDu ShengNuo Biotec
CBL
Piramal Pharma
CPC Scientific

Please note: The report will take approximately 2 business days to prepare and deliver.